https://health-union.com/wp-content/uploads/2022/01/ep-IA1-HU@2x.png
560
1800
Stephen Wilson
/wp-content/uploads/2021/06/health-union-logo-07-300x90-1.png
Stephen Wilson2022-01-11 14:41:162023-05-04 10:03:36Survey: Focal Seizures Lead to Complex Epilepsy Treatment JourneyPeruse Health Union’s latest news announcements on survey findings, awards, leadership, and more. News media interested in learning more about how Health Union can help them tell the health stories they want to tell can visit our Press Kit and Resource Center for News Media.
https://health-union.com/wp-content/uploads/2022/01/ep-IA1-HU@2x.png
560
1800
Stephen Wilson
/wp-content/uploads/2021/06/health-union-logo-07-300x90-1.png
Stephen Wilson2022-01-11 14:41:162023-05-04 10:03:36Survey: Focal Seizures Lead to Complex Epilepsy Treatment Journey
https://health-union.com/wp-content/uploads/2021/11/HU-featured-image-Press-Release-111821.jpg
784
2055
Stephen Wilson
/wp-content/uploads/2021/06/health-union-logo-07-300x90-1.png
Stephen Wilson2021-11-19 12:19:472022-01-28 12:39:20Survey: Treatment Plan Discussions Differ from Adherence Challenges
https://health-union.com/wp-content/uploads/2020/03/Forbes-award-press-release-2020.jpg
616
1615
Stephen Wilson
/wp-content/uploads/2021/06/health-union-logo-07-300x90-1.png
Stephen Wilson2021-11-17 10:54:492023-05-05 10:03:03Health Union Ranks No. 449 in 2021 Deloitte Technology Fast 500
https://health-union.com/wp-content/uploads/2020/10/HU-featured-image-Press-Release-100720.jpg
560
1468
Stephen Wilson
/wp-content/uploads/2021/06/health-union-logo-07-300x90-1.png
Stephen Wilson2021-10-25 14:05:112023-05-05 09:37:25Quality of Life Impact Research Presented at Three Fall ConferencesSurvey: Focal Seizures Lead to Complex Epilepsy Treatment Journey
Respondents with focal seizures were more likely than those who aren’t to currently be using prescription medications and various alternative therapies.
Survey: Treatment Plan Discussions Differ from Adherence Challenges
With the highest percentage, 27% of respondents said they viewed cost as a challenge to staying on their medication as prescribed or instructed.
Health Union Ranks No. 449 in 2021 Deloitte Technology Fast 500
Health Union ranked No. 449 on Deloitte’s 2021 Technology Fast 500™, continuing to experience exponential growth since the company started in 2010.
Quality of Life Impact Research Presented at Three Fall Conferences
The findings focus on the patient-reported impact of cystic fibrosis, hidradenitis suppurativa and spondyloarthritis on various quality of life factors.